Immunicum announces corporate rebranding and name change to Mendus AB.
The rebranding reflects an advancing pipeline in next generation cancer immunotherapies, upcoming manufacturing expansion, and long-term corporate aspirations, states the company.
"The name Mendus captures our continued commi